Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.
Orignial Source:
https://www.foxbusiness.com/healthcare/eli-lillys-tirzepatide-off-fdas-shortage-list-what-means-patients